Car T Cell Therapy Market : Table of Content


  • Published On : Nov-2019 |
  • Pages : 150 Pages |
  • Format : Car T Cell Therapy Market Car T Cell Therapy Market Car T Cell Therapy Market Car T Cell Therapy Market

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Key Market Trends

    1.3. Market Share Analysis, By Taxonomy

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Success Factors

    3.1. Iceberg Analysis

    3.2. Revenue Opportunity Analysis

    3.3. Parent Market Analysis

    3.4. Pipeline Assessment

    3.5. Potential Population Eligible for CAR T-cell Therapy, By Region

    3.6. List of Authorized Treatment Centers in the U.S. & U.K.

    3.7. Key Inclusion & Exclusion

4. Global CAR T-Cell Therapy Market Demand (in Value or Size in US$ Mn) Analysis 2017–2018 and Forecast, 2019–2026

    4.1. Historical Market Value (US$ Mn) Analysis, 2017–2018

    4.2. Current and Future Market Value (US$ Mn) Projections, 2019–2026

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Increase in Healthcare Spending  

        5.1.2. Emergence of Academia as the Primary Organization for Carrying Out Research

        5.1.3. Collaborative Efforts and Initiatives to Identify Therapies for Difficult-To-Treat Illnesses

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Increasing Availability of CAR T-cell Therapy

        5.2.2. Increasing Adoption of CAR T-cell Therapy

        5.2.3. Superior Product Efficacy

        5.2.4. Improving Reimbursement Scenario

        5.2.5. Collaboration among Pharmaceutical and Biopharmaceutical Companies

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. Global CAR T-Cell Therapy Market Analysis 2017–2018 and Forecast 2019–2026, by Product Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size (US$ Mn) and Analysis By Product Type, 2017–2018

    6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019–2026

        6.3.1. Yescarta (axicabtagene ciloleucel)

        6.3.2. Kymriah (tisagenlecleucel)

        6.3.3. JCAR017 (lisocabtagene maraleucel)

        6.3.4. bb2121 Market Attractiveness Analysis By Product Type

7. Global CAR T-Cell Therapy Market Analysis 2017–2018 and Forecast 2019–2026, by Indication

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Mn) Analysis By Indication, 2017–2018

    7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2019–2026

        7.3.1. Relapsed Large B-cell Lymphoma

        7.3.2.  Acute Lymphoblastic Leukemia (ALL)

        7.3.3. Multiple Myeloma

    7.4. Market Attractiveness Analysis By Indication

8. Global CAR T-Cell Therapy Market Analysis 2017–2018 and Forecast 2019–2026, by End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2018

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019–2026

        8.3.1. Hospitals

        8.3.2. Cancer Treatment Centers

    8.4. Market Attractiveness Analysis By End User

9. Global CAR T-Cell Therapy Market Analysis 2017–2018 and Forecast 2019–2026, by Region

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn Analysis By Region, 2017–2018

    9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019–2026

        9.3.1. North America

        9.3.2. Europe

        9.3.3. Japan

    9.4. Market Attractiveness Analysis By Region

10. North America CAR T-Cell Therapy Market Analysis 2017–2018 and Forecast 2019–2026

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2018

    10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019–2026

        10.3.1.  By Country

            10.3.1.1. U.S.

            10.3.1.2. Canada

        10.3.2. By Product Type

        10.3.3. By Indication

        10.3.4. By End User

    10.4. Market Attractiveness Analysis

    10.5. Key Market Participants - Intensity Mapping

    10.6. Drivers and Restraints - Impact Analysis

11. Europe CAR T-Cell Therapy Market Analysis 2017–2018 and Forecast 2019–2026

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2018

    11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019–2026

        11.3.1.  By Country

            11.3.1.1. Germany

            11.3.1.2. Italy

            11.3.1.3. France

            11.3.1.4. U.K.

            11.3.1.5. Spain

            11.3.1.6. Rest of Europe

        11.3.2. By Product Type

        11.3.3. By Indication

        11.3.4. By End User

    11.4. Market Attractiveness Analysis

    11.5. Key Market Participants - Intensity Mapping

    11.6. Drivers and Restraints - Impact Analysis

12. Japan CAR T-Cell Therapy Market Analysis 2017–2018 and Forecast 2019–2026

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2018

    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019–2026

        12.3.1. By Product Type

        12.3.2. By Indication

        12.3.3. By End User

    12.4. Market Attractiveness Analysis

    12.5. Key Market Participants - Intensity Mapping

    12.6. Drivers and Restraints - Impact Analysis

13. Market Structure Analysis

    13.1. Market Analysis by Tier of Companies (CAR T-Cell Therapy)

    13.2. Market Share Analysis of Top Players

    13.3. Market Presence Analysis

        13.3.1. By Regional footprint of Players

        13.3.2. Treatment foot print by Players

        13.3.3. Channel Foot Print by Players

14. Competition Analysis

    14.1. Competition Dashboard

    14.2. Pricing Analysis by Competition

    14.3. Competition Benchmarking

    14.4. Competition Deep Dive 

        14.4.1. Novartis AG

            14.4.1.1. Overview

            14.4.1.2. Drug Portfolio

            14.4.1.3. Profitability by Market Segments (Drug/Channel/Region)

            14.4.1.4. Sales Footprint

            14.4.1.5. Strategy Overview

                14.4.1.5.1. Marketing Strategy

                14.4.1.5.2. Drug Strategy

                14.4.1.5.3. Channel Strategy

        14.4.2. Gilead Sciences Inc.

            14.4.2.1. Overview

            14.4.2.2. Drug Portfolio

            14.4.2.3. Profitability by Market Segments (Drug/Channel/Region)

            14.4.2.4. Sales Footprint

            14.4.2.5. Strategy Overview

                14.4.2.5.1. Marketing Strategy

                14.4.2.5.2. Drug Strategy

                14.4.2.5.3. Channel Strategy

        14.4.3. Celgene Corporation

            14.4.3.1. Overview

            14.4.3.2. Drug Portfolio

            14.4.3.3. Profitability by Market Segments (Drug/Channel/Region)

            14.4.3.4. Sales Footprint

            14.4.3.5. Strategy Overview

                14.4.3.5.1. Marketing Strategy

                14.4.3.5.2. Drug Strategy

                14.4.3.5.3. Channel Strategy

        14.4.4. bluebird bio, Inc.

            14.4.4.1. Overview

            14.4.4.2. Drug Portfolio

            14.4.4.3. Profitability by Market Segments (Drug/Channel/Region)

            14.4.4.4. Sales Footprint

            14.4.4.5. Strategy Overview

                14.4.4.5.1. Marketing Strategy

                14.4.4.5.2. Drug Strategy

                14.4.4.5.3. Channel Strategy

15. Assumptions and Acronyms Used

16. Research Methodology


List of Tables

Table 01: CAR T-Cell Therapy, Pipeline Assessment

Table 02: CAR T-Cell Therapy, Pipeline Assessment

Table 03: CAR T-Cell Therapy, Pipeline Assessment

Table 04: CAR T-Cell Therapy, Pipeline Assessment

Table 05: CAR T-Cell Therapy, Pipeline Assessment

Table 06: CAR T-Cell Therapy, Pipeline Assessment

Table 07: CAR T-Cell Therapy, Pipeline Assessment

Table 08: CAR T-Cell Therapy, Pipeline Assessment

Table 09: CAR T-Cell Therapy, Pipeline Assessment

Table 10: CAR T-Cell Therapy, Pipeline Assessment

Table 11: CAR T-Cell Therapy, Pipeline Assessment

Table 12: CAR T-Cell Therapy, Pipeline Assessment

Table 13: CAR T-Cell Therapy, Pipeline Assessment

Table 14: CAR T-Cell Therapy, Pipeline Assessment

Table 15: CAR T-Cell Therapy, Pipeline Assessment

Table 16: CAR T-Cell Therapy, Pipeline Assessment

Table 17: CAR T-Cell Therapy, Pipeline Assessment

Table 18: CAR T-Cell Therapy, Pipeline Assessment

Table 19: CAR T-Cell Therapy, Pipeline Assessment

Table 20: CAR T-Cell Therapy, Pipeline Assessment

Table 21: CAR T-Cell Therapy, Pipeline Assessment

Table 22: CAR T-Cell Therapy, Pipeline Assessment

Table 23: CAR T-Cell Therapy, Pipeline Assessment

Table 24: CAR T-Cell Therapy, Pipeline Assessment

Table 25: CAR T-Cell Therapy, Pipeline Assessment

Table 26: CAR T-Cell Therapy, Pipeline Assessment

Table 27: Treatment Centers Authorized to Administer CAR T-Cell Therapy in the U.S.

Table 28: Treatment Centers Authorized to Administer CAR T-Cell Therapy in the U.S.

Table 29: Treatment Centers Authorized to Administer CAR T-Cell Therapy in the U.S.

Table 30: Treatment Centers Authorized to Administer CAR T-Cell Therapy in the U.S.

Table 31: Treatment Centers Authorized to Administer CAR T-Cell Therapy in the U.K.

Table 32: Global CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Product Type

Table 33: Global CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Indication

Table 34: Global CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By End User

Table 35: Global CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Region

Table 36: North America CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Country

Table 37: North America CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Product Type

Table 38: North America CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Indication

Table 39: North America CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By End User

Table 40: Europe CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Country

Table 41: Europe CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Product Type

Table 42: Europe CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Indication

Table 43: Europe CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By End User

Table 44: Japan CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Product Type

Table 45: Japan CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Indication

Table 46: Japan CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By End User


List of Figures

Figure 01: CAR T-Cell Therapy Market Value ($ Mn), By Country, 2018 & 2026

Figure 02: Global CAR T-Cell Therapy Market Value Share By Product Type (2019E)

Figure 03: Global CAR T-Cell Therapy Market Value Share By Indication (2019E)

Figure 04: Global CAR T-Cell Therapy Market Value Share By End User (2019E)

Figure 05: Global CAR T-Cell Therapy Market Value Share By Region (2019E)

Figure 06: CAR T-Cell Therapy, Pipeline Assessment

Figure 07: Global CAR T-Cell Therapy Market Value Analysis (US$ Mn), 2017-2018

Figure 08: Global CAR T-Cell Therapy Market Value Analysis (US$ Mn), 2019–2026

Figure 09: Global CAR T-Cell Therapy Market Absolute $ Opportunity, 2017-2018

Figure 10: Global CAR T-Cell Therapy Market Absolute $ Opportunity, 2019-2026

Figure 11: Global CAR T-Cell Therapy Market Share Analysis (%) By Product Type, 2019 & 2026

Figure 12: Global CAR T-Cell Therapy Market Y-o-Y Growth (%) By Product Type, 2019-2026

Figure 13: Global CAR T-Cell Therapy Market Attractiveness Analysis, By Product Type

Figure 14: Global CAR T-Cell Therapy Market Share Analysis (%) By Indication, 2019 & 2026

Figure 15: Global CAR T-Cell Therapy Market Y-o-Y Growth (%) By Indication, 2019-2026

Figure 16: Global CAR T-Cell Therapy Market Attractiveness Analysis, By Indication

Figure 17: Global CAR T-Cell Therapy Market Share Analysis (%) By End User, 2019 & 2026

Figure 18: Global CAR T-Cell Therapy Market Y-o-Y Growth (%) By End User, 2019-2026

Figure 19: Global CAR T-Cell Therapy Market Attractiveness Analysis, By End User

Figure 20: Global CAR T-Cell Therapy Market Share Analysis (%) By Region, 2019 & 2026

Figure 21: Global CAR T-Cell Therapy Market Y-o-Y Growth (%) By Region, 2019-2026

Figure 22: Global CAR T-Cell Therapy Market Attractiveness Analysis, By Region

Figure 23: North America CAR T-Cell Therapy Market Size (US$ Mn), 2017-2018

Figure 24: North America CAR T-Cell Therapy Market Size (US$) & Y-o-Y Growth (%), 2019-2026

Figure 25: North America CAR T-Cell Therapy Market Analysis by Country – 2019 & 2026

Figure 26: North America CAR T-Cell Therapy Market Y-o-Y Growth Projections by Country, 2019-2026

Figure 27: North America CAR T-Cell Therapy Market Attractiveness Analysis by Country, 2019-2026

Figure 28: North America CAR T-Cell Therapy Market Analysis by Product Type – 2019 & 2026

Figure 29: North America CAR T-Cell Therapy Market Y-o-Y Growth Projections by Product Type, 2019-2026

Figure 30: North America CAR T-Cell Therapy Market Attractiveness Analysis by Product Type, 2019-2026

Figure 31: North America CAR T-Cell Therapy Market Analysis by Indication –2019 & 2026

Figure 32: North America CAR T-Cell Therapy Market Y-o-Y Growth Projections by Indication, 2019-2026

Figure 33: North America CAR T-Cell Therapy Market Attractiveness Analysis by Indication, 2019-2026

Figure 34: North America CAR T-Cell Therapy Market Analysis by End User –2019 & 2026

Figure 35: North America CAR T-Cell Therapy Market Y-o-Y Growth Projections by End User, 2019-2026

Figure 36: North America CAR T-Cell Therapy Market Attractiveness Analysis by End User, 2019-2026

Figure 37: Europe CAR T-Cell Therapy Market Size (US$ Mn), 2017-2018

Figure 38: Europe CAR T-Cell Therapy Market Size (US$) & Y-o-Y Growth (%), 2019-2026

Figure 39: Europe CAR T-Cell Therapy Market Analysis by Country – 2019 & 2026

Figure 40: Europe CAR T-Cell Therapy Market Y-o-Y Growth Projections by Country, 2019-2026

Figure 41: Europe CAR T-Cell Therapy Market Attractiveness Analysis by Country, 2019-2026

Figure 42: Europe CAR T-Cell Therapy Market Analysis by Product Type – 2019 & 2026

Figure 43: Europe CAR T-Cell Therapy Market Y-o-Y Growth Projections by Product Type, 2019-2026

Figure 44: Europe CAR T-Cell Therapy Market Attractiveness Analysis by Product Type, 2019-2026

Figure 45: Europe CAR T-Cell Therapy Market Analysis by Indication –2019 & 2026

Figure 46: Europe CAR T-Cell Therapy Market Y-o-Y Growth Projections by Indication, 2019-2026

Figure 47: Europe CAR T-Cell Therapy Market Attractiveness Analysis by Indication, 2019-2026

Figure 48: Europe CAR T-Cell Therapy Market Analysis by End User –2019 & 2026

Figure 49: Europe CAR T-Cell Therapy Market Y-o-Y Growth Projections by End User, 2019-2026

Figure 50: Europe CAR T-Cell Therapy Market Attractiveness Analysis by End User, 2019-2026

Figure 51: Japan CAR T-Cell Therapy Market Size (US$ Mn), 2017-2018

Figure 52: Japan CAR T-Cell Therapy Market Size (US$) & Y-o-Y Growth (%), 2019-2026

Figure 53: Japan CAR T-Cell Therapy Market Analysis by Product Type – 2019 & 2026

Figure 54: Japan CAR T-Cell Therapy Market Y-o-Y Growth Projections by Product Type, 2019-2026

Figure 55: Japan CAR T-Cell Therapy Market Attractiveness Analysis by Product Type, 2019-2026

Figure 56: Japan CAR T-Cell Therapy Market Analysis by Indication –2019 & 2026

Figure 57: Japan CAR T-Cell Therapy Market Y-o-Y Growth Projections by Indication, 2019-2026

Figure 58: Japan CAR T-Cell Therapy Market Attractiveness Analysis by Indication, 2019-2026

Figure 59: Japan CAR T-Cell Therapy Market Analysis by End User –2019 & 2026

Figure 60: Japan CAR T-Cell Therapy Market Y-o-Y Growth Projections by End User, 2019-2026

Figure 61: Japan CAR T-Cell Therapy Market Attractiveness Analysis by End User, 2019-2026

Figure 62: Company Market Share Analysis, 2018

Car T Cell Therapy Market - Table of Content

Back To Top